Tag: pipeline

“Trump’s victory could mean the end of Obamacare. Is right now a good time to invest in pharmaceutical stocks?”

Learn everything an investor needs to know about investing in pharmaceuticals.

Get My Free Report
_{Click here to download for free}

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Food and Drug Administration (“FDA”) has allowed an additional Investigational New Drug Application (“IND”) to study its lead drug candidate VAL-083 as a potential treatment for ovarian cancer.

“The opening of this

5 Top Weekly TSXV Stocks: Jayden Resources Gains on Start of Drill Program

By Melissa Shaw

Last week’s top-gaining stocks on the TSXV were American Manganese, Stakeholder Gold, GB Minerals and International Lithium.

5 Top NASDAQ Biotech Stocks: Kura Takes the Week

By Bryan Mc Govern

CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.

Cannabis Weekly Round-Up: LPs Sign Deal with New Brunswick for Recreational Cannabis

By Bryan Mc Govern

The Investing News rounds some of the biggest news in the cannabis market for the past trading week

Advantage Lithium CEO David Sidoo

By Investing News Network

Advantage Lithium President and CEO David Sidoo discusses how a partnership with Orocobre has set his company up for success as a junior lithium explorer.

Top 10 Stem Cell Companies On The NASDAQ

By Bryan Mc Govern

The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021. Here are 10 top stem cell companies on the NASDAQ.

What is Cleantech Investing?

By Jocelyn Aspa

Clean tech investing spans many industry verticals, and refers to products and technologies that aim to reduce negative impacts on the environment.

Anaconda Mining Sells a Record 4,723 Ounces of Gold in Q1 FY2018, Generating over $7.6m in Revenue

By Shelly Kumar

Anaconda Mining Inc. (“Anaconda” or the “Company”) (TSX:ANX) is pleased to announce production results and certain financial information from its fiscal first quarter ended August 31, 2017. All dollar amounts are in Canadian Dollars. The Company expects to file its first quarter financial statements and management discussion and analysis by October 12,

Mustang Bio Announces Expansion of CAR T Pipeline

By Bryan Mc Govern

Mustang Bio announced the expansion of its pipeline of CAR T therapies into CD20-directed immunotherapies.

AGTC Released its Financial Results for Fiscal Year

By Bryan Mc Govern

Applied Genetic Technologies announced its financial results for its latest quarter and fiscal year.

Liberty Gold Announces Drill Results from the Western Zone and Main Zone at Goldstrike, Utah

By Investing News Network

Liberty Gold Inc. (TSX:LGD) (“Liberty Gold” or the “Company”) is pleased to announce additional drill results from the Western Zone and Main Zone at the 100% controlled Goldstrike Oxide Gold Project in southwestern Utah. In both areas, drilling is currently focused on amalgamating mineralization over large areas into single zones

Onesoft’s Subsidiary Contracts with Phillips 66

By Bryan Mc Govern

OneSoft Solutions announced its wholly owned subsidiary OneBridge Solutions contracted with Phillips 66 for the commercial use of their Cognitive Integrity Management SaaS solution.

5 Biggest Pharmaceutical Companies by Market Cap

By Morag McGreevey

Major players in the pharmaceutical industry include Johnson & Johnson, Novartis, Roche, Pfizer and Merck.

DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme

By Shelly Kumar

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced the initiation of a Phase 2 clinical trial for its lead agent VAL-083 in newly diagnosed MGMT-unmethylated glioblastoma multiforme (GBM). The biomarker-driven clinical trial will explore safety and efficacy of chemoradiation with VAL-083 as

5 Top Weekly TSXV Stocks: Nickel-focused Companies Lead the Charge

By Charlotte McLeod

Last week’s top-gaining TSXV stocks were Asian Mineral Resources, Garibaldi Resources, Niobay Metals, FPX Nickel and Noble Mineral Exploration.

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

By Shelly Kumar

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of respiratory disorders, including sleep apnea, opioid-induced respiratory depression, and respiratory insufficiency due to spinal cord injury, announces that the Company’s Chief Executive Officer and Vice Chairman of the Board of Directors, James

What is Personalized Medicine?

By Bryan Mc Govern

What if the “one-size-fits-all” approach to medicine isn’t the right way treat medical conditions? Could a personalized medicine approach provide better treatment?

Anaconda Mining Strengthens Point Rousse Infrastructure Through Approval of a 7 Mt Tailings Facility

By Shelly Kumar

Anaconda Mining Inc. (“Anaconda” or the “Company”) – (TSX:ANX) is pleased to announce that it has received approval from the Newfoundland and Labrador Department of Natural Resources to amend the Pine Cove Property Development Plan and Rehabilitation and Closure Plan to utilize the Pine Cove Pit at the Point Rousse Project as

WeedMD Retains Stoic Advisory to Accelerate Corporate Initiatives

By Shelly Kumar

WeedMD Inc. (TSX-V:WMD),, a federally licensed producer and distributor of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pleased to announce it has entered into a consulting services agreement with Stoic Advisory Inc. (“Stoic”), to support the Company with ongoing business development initiatives and capital markets

GT Biopharma Appoints Former Pfizer Executive as Chief Medical Officer

By Bryan Mc Govern

GT Biopharma announced the appointment of Dr. Raymond Urbanski as their new chief medical officer.

“Trump’s victory could mean the end of Obamacare. Is right now a good time to invest in pharmaceutical stocks?”

Learn everything an investor needs to know about investing in pharmaceuticals.

Get My Free Report
_{Click here to download for free}

Tag: pipeline

“Trump’s victory could mean the end of Obamacare. Is right now a good time to invest in pharmaceutical stocks?”

“Trump’s victory could mean the end of Obamacare. Is right now a good time to invest in pharmaceutical stocks?”

Enter Your Log In Credentials

Privacy & Legal Policy